Monday, March 18, 2019 7:03:48 AM
BioCann Management in this communication with shareholders sets out an initial overview of their existing business interests and confirms that BioCann has an equal partnership with Instadose Pharma S.A.S. in Colombia, which is a subsidiary of Canadian based Instadose Pharma Corp. ("Instadose"), www.instadosepharma.com.
https://finance.yahoo.com/news/gncc-capital-inc-updates-recently-100000734.html
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
